Chugai Seiyaku Kabushiki Kaisha & Anr v. Anthem Biosciences Limited

32966008

The Plaintiffs filed a commercial suit seeking to restrain the Defendant from dealing in products that infringe their patent (IN 294424) related to Alectinib. The court addressed several interlocutory applications, including those for document production and exemption from mediation. In the main application for interim injunction, the Defendant provided an undertaking not to launch infringing products.

Jurisdiction
India
Court
Delhi High Court - Orders
Case Number
32966008
Decision Date
22 August 2025

Detailed Summary

In the high-stakes world of pharmaceutical patents, the battle lines are often drawn long before a final verdict is reached. For startups and established companies alike, how you handle the initial skirmishes can dictate the survival of your product and your capital. This case illustrates a classic scenario where the threat of immediate market

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Chugai Seiyaku Kabushiki Kaisha & Anr vs Anthem Biosciences Limited is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent1600149

Poysha Industries Co. Ltd.vsDy. Controller Of Patents And Designs

Poysha Industries Co. Ltd. appealed against a decision regarding a patent application filed by Metal Box Company of India Ltd. The appeal focused on whether the claimed pil-ferproof container closure had been publicly used or known in India before the filing date. The court found that the appellants failed to establish prior public use, leading to the dismissal of the appeal.

patent63566003

Reata Pharmaceuticals IncvsDeputy Controller Of Patents And Design

Reata Pharmaceuticals Inc appealed the Deputy Controller's order rejecting its patent application for 'NOVEL FORMS Of CDDO METHYL ESTER' on grounds of non-patentability under Sections 3(d) and 3(e). The appellant argued that the rejection failed to consider crucial clinical trial data demonstrating enhanced therapeutic efficacy. The High Court set aside the impugned order, holding that the authority must deal with all submitted evidence and provide reasoned orders.

patent137662798

Pstgems Private LimitedvsActive Ayurvedic Life Private Limited & Ors.

The Delhi High Court granted the plaintiff, Pstgems Private Limited, an ex parte ad-interim injunction in a suit alleging infringement and passing off related to its trademark 'BRAMPIUM' and associated copyrights. The court recognized the urgency of the matter concerning counterfeit products and ordered the appointment of a Local Commissioner. This commissioner is tasked with accessing Defendant No. 1's premises, reviewing CCTV footage, and examining account books and stock registers to gather evidence of infringement.

patent159320823

IFB Industries LimitedvsMehul Bharatbhai Vavdiya And Others

The Calcutta High Court admitted the plaint in the case of IFB Industries Limited vs Mehul Bharatbhai Vavdiya And Others. The court granted leave under relevant procedural rules, allowing the matter to proceed for scrutiny by the Department.

patent147423954

F.Hoffmann-La Roche LtdvsNatco Pharma Limited

F.Hoffmann-La Roche Ltd filed a petition seeking the revocation of Patent No. 236791 from the patent register. However, the petitioner subsequently instructed their counsel to withdraw the petition.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call